What is ArcScan?
ArcScan specializes in robotic ultrasound technology designed to enhance ophthalmic imaging, with a particular focus on applications within refractive surgery. Their primary product, the Insight 100, is engineered to deliver precise imaging and critical data essential for surgical planning. By providing detailed insights into ocular anatomy, ArcScan aims to bolster clinical confidence and improve patient outcomes, empowering ophthalmic surgeons and practices dedicated to cutting-edge eye care solutions.
How much funding has ArcScan raised?
ArcScan has raised a total of $3.7M across 1 funding round:
Private Equity
$3.7M
Private Equity (2015): $3.7M, investors not publicly disclosed
What's next for ArcScan?
With the recent major strategic investment, ArcScan is poised to accelerate its growth and market penetration. The enterprise-level funding context suggests the company is moving towards scaling its operations, expanding its product reach, and potentially further developing its robotic ultrasound platform. This capital infusion is expected to fuel research and development, enhance manufacturing capabilities, and strengthen its commercialization efforts within the competitive medical technology landscape. ArcScan's trajectory indicates a commitment to becoming a leader in advanced ophthalmic diagnostics.
See full ArcScan company page
